Old Web
English
Sign In
Acemap
>
Paper
>
Editorial: fenofibrate as second‐line therapy in high risk PBC – more answers or more questions? Authors' reply
Editorial: fenofibrate as second‐line therapy in high risk PBC – more answers or more questions? Authors' reply
2016
A. C. Cheung
Matthew Kowgier
Jordan J. Feld
Keywords:
Fenofibrate
Diabetes mellitus
Pathology
Gastroenterology
Internal medicine
Second-line therapy
Medicine
Ursodeoxycholic acid
Correction
Source
Cite
Save
Machine Reading By IdeaReader
3
References
1
Citations
NaN
KQI
[]